Who are Centessa Pharmaceuticals's investors?

Centessa Pharmaceuticals's investors include Advent Life Sciences, EcoR1 Capital, Foresite Capital, General Atlantic, LifeSci Venture Partners, Medicxi, Oberland Capital, Scion Life Sciences and 3 more.

Centessa Pharmaceuticals

11 known investors

Find your way into Centessa Pharmaceuticals

Paths you didn't know you had: your email and LinkedIn already hold routes to the Centessa Pharmaceuticals team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders. It focuses on drug development for patients with these conditions.

Biotech Healthtech

Investors · 11

Advent Life Scienceslisted by Advent Life SciencesLondon

How we know: Advent Life Sciences's portfolio page · Not right? Tell us

EcoR1 Capitallisted by EcoR1 CapitalSan Francisco

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · Not right? Tell us

General Atlanticlisted by General AtlanticNew York · $10M – $1B

How we know: a partner's Signal profile · generalatlantic.com · Not right? Tell us

LifeSci Venture Partnerslisted by LifeSci Venture PartnersNew York

How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us

Medicxilisted by MedicxiLondon

How we know: Medicxi's portfolio page · Not right? Tell us

Oberland Capitallisted by Oberland CapitalNew York

Scion Life Scienceslisted by Scion Life SciencesNew York · $1K – $60M

How we know: Scion Life Sciences's portfolio page · Not right? Tell us

Vida Ventureslisted by Vida VenturesLos Angeles

How we know: Vida Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M

Cambridge Innovation CapitalreportedCambridge · $127K – $12.7M

How we know: the VCSheet dataset · Not right? Tell us

Founder mafia

2 people who came through Centessa Pharmaceuticals went on to found or lead other companies.

Arjun GoyalMember Board Of DirectorsFounded Affini-T Therapeutics Samarth KulkarniBoard MemberFounded CRISPR

Related companies · 2

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies working in the same space as Centessa Pharmaceuticals.

Frequently asked questions

What does Centessa Pharmaceuticals do?: Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders. It focuses on drug development for patients with these conditions.
Who are Centessa Pharmaceuticals's investors?: Centessa Pharmaceuticals's investors include Advent Life Sciences, EcoR1 Capital, Foresite Capital, General Atlantic, LifeSci Venture Partners, Medicxi, Oberland Capital, Scion Life Sciences and 3 more.